MicroRNA signatures of resveratrol in the ischemic heart.
Until the middle of the last decade, few people had heard of microRNAs (miRNAs), 21- to 23-nucleotide conserved RNAs. MicroRNAs represent a new paradigm because they regulate most physiological processes and thus have immense potential for medical advancement. Resveratrol, a red wine-derived polyphenolic compound, has been shown to have significant effects in various disease models, such as cardioprotection in ischemic heart, diabetes, and chemoprevention of cancers. The targets of resveratrol include various pathways and molecules, such as sirtuins, FOXOs, and autophagy. The successful application of resveratrol lies in understanding its mechanisms of action through direct and indirect interactions with pathways, including miRNAs. For example, a unique miRNA footprint is present in the heart treated with resveratrol. Targets of those miRNAs have potential implications for physiological and pathophysiological processes in health and disease.
Laboratory of Physiologic Studies, NIAAA, National Institute of Health, Bethesda, Maryland, USA. mpartha@mail.nih.gov
Partha
P
Mukhopadhyay
Pal
P
Pacher
Dipak K
DK
Das
D000818:Animals; D006801:Humans; D035683:MicroRNAs / Q000096:biosynthesis*; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000378:metabolism* / Q000503:physiopathology; D000077185:Resveratrol; D013267:Stilbenes / Q000378:metabolism / Q000627:therapeutic use*
D035683:MicroRNAs; D013267:Stilbenes; D000077185:Resveratrol
FEBS Lett. 2005 Oct 31;579(26):5822-9
16214139
Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9793-8
18599449
Annu Rev Biochem. 2010;79:295-319
20205586
Aging (Albany NY). 2010 Jul;2(7):415-31
20634564
Cancer Lett. 2009 Oct 18;284(1):1-6
19261378
Science. 2007 Dec 21;318(5858):1931-4
18048652
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):18002-7
17071740
Heart Fail Rev. 2010 Sep;15(5):467-77
20238161
Eur J Pharmacol. 2007 Jul 30;568(1-3):269-77
17573071
Mol Cell. 2008 May 23;30(4):460-71
18498749
Mol Nutr Food Res. 2005 May;49(5):472-81
15779070
J Cardiovasc Pharmacol. 2009 Dec;54(6):468-76
19770673
Nature. 2008 Dec 18;456(7224):980-4
19043405
Mol Nutr Food Res. 2005 May;49(5):405-30
15832402
RNA. 2010 May;16(5):1032-9
20348442
Eur J Pharmacol. 2010 Jun 10;635(1-3):1-8
20303945
Drugs Exp Clin Res. 1999;25(2-3):115-20
10370873
Recent Pat Cardiovasc Drug Discov. 2007 Jun;2(2):133-8
18221111
J Biol Chem. 2009 Aug 28;284(35):23204-16
19574223
Am J Physiol Heart Circ Physiol. 2005 Jan;288(1):H328-35
15345477
Exp Clin Cardiol. 2010 Winter;15(4):e134-8
21264071
Circ Res. 2010 Sep 3;107(5):677-84
20595655
J Cell Mol Med. 2010 Oct;14(10):2506-18
19799646
Circ Res. 2010 May 14;106(9):e8; author reply e9
20466983
Circulation. 2008 Oct 7;118(15):1567-76
18809798
Cardiovasc Res. 2009 Apr 1;82(1):21-9
19147652
Cell. 2007 Mar 23;128(6):1105-18
17382880
Lancet. 1993 Apr 24;341(8852):1103-4
8097009
Nat Med. 2007 Apr;13(4):486-91
17401374
J Am Coll Cardiol. 2010 Jan 12;55(2):91-6
20117376
J Cell Physiol. 2010 Jul;224(1):242-9
20232316
Nat Chem Biol. 2007 Jan;3(1):36-43
17173028
Mol Cell Biol. 1998 Nov;18(11):6548-59
9774670
Dev Biol. 1999 Dec 15;216(2):671-80
10642801
Nat Rev Genet. 2010 Sep;11(9):597-610
20661255
Cardiovasc Res. 2010 Mar 1;85(4):773-84
19942623
Free Radic Res. 1994 Jan;20(1):63-8
8012522
Circulation. 2002 Sep 24;106(13):1652-8
12270858
Arch Biochem Biophys. 2008 Dec 1;480(1):27-32
18835240
Cancer Res. 2009 Apr 15;69(8):3245-8
19351814
Nature. 2009 Jan 22;457(7228):396-404
19158785
J Cardiovasc Pharmacol. 2006 Aug;48(2):1-5
16954814
Circ Res. 2009 Jan 30;104(2):170-8, 6p following 178
19096030
J Cell Mol Med. 2010 Sep;14(9):2235-9
20716127
Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):16961-6
16287976
Curr Opin Cell Biol. 2009 Jun;21(3):452-60
19450959
J Med Food. 2008 Dec;11(4):610-4
19053850
Free Radic Biol Med. 2009 Mar 1;46(5):573-8
19071213
Cardiovasc Res. 2010 Apr 1;86(1):103-12
19959541
Nat Rev Genet. 2008 Feb;9(2):102-14
18197166
Int J Tissue React. 1995;17(1):1-3
7499059
Mol Biol Rep. 1995-1996;22(2-3):75-9
8901491
Nat Prod Res. 2006 Mar;20(3):247-52
16401555
Science. 2001 Feb 16;291(5507):1304-51
11181995
Science. 2006 Apr 7;312(5770):75-9
16484454
Nature. 2004 Sep 16;431(7006):350-5
15372042
Neurotox Res. 2009 Jul;16(1):30-41
19526296
Mol Interv. 2006 Feb;6(1):36-47
16507749
Science. 1999 Oct 29;286(5441):950-2
10542148
Science. 2007 Dec 21;318(5858):1877-8
18096794
Circulation. 2001 Jan 23;103(3):472-5
11157703
J Am Coll Cardiol. 2010 Jul 6;56(2):89-97
20620723
Ann N Y Acad Sci. 1993 May 28;686:299-309
8512256
Curr Drug Targets. 2006 Apr;7(4):423-42
16611030
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13027-32
18723672
FEMS Microbiol Rev. 2010 Sep;34(5):866-82
20662934
Nat Genet. 2006 Feb;38(2):228-33
16380711
Cell. 2005 Aug 26;122(4):553-63
16122423
J Biol Chem. 1997 Apr 18;272(16):10448-56
9099687
Lancet. 1992 Jun 20;339(8808):1523-6
1351198
Nat Struct Mol Biol. 2010 Jan;17(1):5-10
20051982
Science. 2005 Sep 2;309(5740):1573-6
16081698
Gene. 2003 Aug 14;313:1-16
12957374